Does the Overall Survival of the Resectable Periampullary Carcinomas Correlate with High Expression of p53 and ki67?

Chirurgia (Bucur). 2022 Jun;117(4):423-430. doi: 10.21614/chirurgia.2744.

Abstract

Introduction: Periampullary carcinomas represent a group of tumors that develop in a complex area, implying different anatomical structures. The most common histological type of periampullary carcinomas is the adenocarcinoma. The pancreatic type of periampullary adenocarcinomas has the worst prognosis. Immunohistochemical markers, such as ki-67 and p53, can be used in predicting survival. Material and method: we selected the patients with periampullary adenocarcinomas, intestinal or biliopancreatic type, with resectable tumors, and we performed immunohistochemical stains for ki-67 and p53 markers. The overall survival was analyzed according to the expression of immunohistochemical markers, TNM staging, tumor grade and perineural invasion. Results: Sixty-seven patients were included in the study. The median overall survival for the whole cohort was 12 months, with a 2-year survival rate of 25%. High rate of tumor proliferation (ki67 more than 80%) was significantly associated with shorter overall survival (median survival 3 months compared with 17 months for the group with ki67 index less than 80%). A high expression of p53 protein has been associated with low overall survival. The low survival was associated with poorly differentiated tumor grade and lymph node status. Conclusion: Both immunohistochemical expression of ki67 and p53 can be used as prognostic and predictive factors for overall survival of patients with resectable periampullary adenocarcinomas.

Keywords: ki-67; p53; periampullaryadenocarcinomas; prognosis; survival.

MeSH terms

  • Adenocarcinoma* / surgery
  • Carcinoma*
  • Duodenal Neoplasms*
  • Humans
  • Ki-67 Antigen / metabolism
  • Prognosis
  • Treatment Outcome
  • Tumor Suppressor Protein p53 / metabolism

Substances

  • Ki-67 Antigen
  • MKI67 protein, human
  • TP53 protein, human
  • Tumor Suppressor Protein p53